https://news.medxy.ai/zh/biomarkers-sepsis/Medxy AIzh2026-04-28T00:21:04-07:00脓毒症中的生物标志物特征：将宿主反应与临床结果联系起来 https://news.medxy.ai/ja/sepsis-biomarker-signature/Medxy AIja2026-04-28T00:19:52-07:00敗血症におけるバイオマーカー・シグネチャー：宿主反応と臨床結果の関連 https://news.medxy.ai/vi/biomarker-infection-response/Medxy AIvi2026-04-28T00:18:57-07:00Chữ ký sinh học trong nhiễm trùng: Liên kết phản ứng của cơ thể với kết quả lâm sàng https://news.medxy.ai/biomarker-signatures-sepsis/Medxy AIen2026-04-28T00:16:56-07:00Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes https://news.medxy.ai/zh/ecmo-early-resistance-training/Medxy AIzh2026-04-28T00:15:45-07:00ECMO期间早期抗阻训练和垂直化：改善功能结局的安全路径 https://news.medxy.ai/ja/early-rehab-ecmo/Medxy AIja2026-04-28T00:15:13-07:00ECMO中の早期リハビリテーションと垂直化：機能的転帰の改善への安全な道 https://news.medxy.ai/vi/early-resistance-training-ecmo/Medxy AIvi2026-04-28T00:14:21-07:00Huấn luyện kháng cự sớm và đứng thẳng trong quá trình ECMO: Con đường an toàn để cải thiện kết quả chức năng https://news.medxy.ai/early-resistance-training-ecmo/Medxy AIen2026-04-28T00:11:46-07:00Early Resistance Training and Verticalization During ECMO: A Safe Path to Improved Functional Outcomes https://news.medxy.ai/zh/dizziness-stroke-disability-death/Medxy AIzh2026-04-27T23:10:27-07:00头晕急诊出院后的卒中残疾和死亡：罕见但临床意义重大 https://news.medxy.ai/ja/dizziness-emergency-stroke-risk/Medxy AIja2026-04-27T23:09:36-07:00めまい患者の救急外来退院後の脳卒中による障害と死亡：まれだが臨床的に重要 https://news.medxy.ai/vi/stroke-death-post-discharge/Medxy AIvi2026-04-27T23:08:05-07:00Đột quỵ và Tử vong sau Khi Ra Viện cho Bệnh Nhân Bị Hoa Mắt: Hiếm nhưng Có Ý Nghĩa Lâm Sàng https://news.medxy.ai/stroke-disability-mortality-dizziness/Medxy AIen2026-04-27T23:05:40-07:00Stroke Disability and Mortality Post-ED Discharge for Dizziness: Rare but Clinically Significant https://news.medxy.ai/zh/us-dental-pain-opioid-prescriptions/Medxy AIzh2026-04-27T22:57:02-07:00美国牙痛疼痛阿片类药物处方模式的地理差异 https://news.medxy.ai/ja/opioid-prescribing-inequities/Medxy AIja2026-04-27T22:55:38-07:00米国における歯痛のためのオピオイド処方パターンの地理的不均衡 https://news.medxy.ai/vi/geographic-differences-opioid-models/Medxy AIvi2026-04-27T22:54:30-07:00Sự Khác Biệt Địa Lý trong Mô Hình Kê Đơn Opioid để Điều Trị Đau Răng ở Hoa Kỳ https://news.medxy.ai/opioid-prescribing-disparities/Medxy AIen2026-04-27T22:51:49-07:00Geographic Disparities in Opioid Prescribing Patterns for Toothache Pain in the United States https://news.medxy.ai/zh/fecal-microbiota-transplant-failure-2/Medxy AIzh2026-04-27T22:41:59-07:00粪便微生物群移植未能清除胃肠病患者的多重耐药菌：随机试验分析 https://news.medxy.ai/ja/fecal-microbiota-transplant-failure-3/Medxy AIja2026-04-27T22:40:44-07:00糞便微生物移植が多剤耐性菌の脱植民化に失敗：ランダム化試験分析 https://news.medxy.ai/vi/antibiotic-resistant-pathogens/Medxy AIvi2026-04-27T22:38:50-07:00Chuyển Ghép Vi Sinh Vật Phân Không Thành Công Trong Việc Loại Bỏ Các Chủng Vi Sinh Vật Đề kháng Đa Thuốc ở Bệnh Nhân Hô Hấp: Phân Tích Thử Nghiệm Ngẫu Nhiên https://news.medxy.ai/fecal-microbiota-transplant-failure/Medxy AIen2026-04-27T22:34:55-07:00Fecal Microbiota Transplant Fails to Decolonize Multidrug-Resistant Organisms in GI Patients: A Randomized Trial Analysis https://news.medxy.ai/zh/chronic-low-back-pain-physiotherapy/Medxy AIzh2026-04-27T21:09:51-07:00慢性下腰痛：物理治疗作为一线治疗优于认知行为疗法 https://news.medxy.ai/ja/chronic-back-pain-therapy-2/Medxy AIja2026-04-27T21:08:47-07:00慢性腰部疼痛：物理療法在初期治療中優於認知行為療法 https://news.medxy.ai/vi/chronic-back-pain-therapy-3/Medxy AIvi2026-04-27T21:08:01-07:00Đau lưng mãn tính: Vật lý trị liệu hiệu quả hơn CBT trong điều trị đầu tiên https://news.medxy.ai/chronic-back-pain-therapy/Medxy AIen2026-04-27T21:05:37-07:00Chronic Low Back Pain: Physical Therapy Outperforms CBT as First-Line Treatment https://news.medxy.ai/zh/allogeneic-stem-cell-transplant-high-risk-leukemia/Medxy AIzh2026-04-27T18:54:30-07:00异基因造血干细胞移植改善高危t(6;9)急性髓系白血病患者的生存率，尤其是年轻患者和首次完全缓解的患者 https://news.medxy.ai/ja/cell-transplant-aml-survival/Medxy AIja2026-04-27T18:53:02-07:00他家細胞移植が高リスクt(6;9) AMLの生存率を改善、特に若年患者とCR1達成者で顕著 https://news.medxy.ai/vi/cord-blood-transplant-aml/Medxy AIvi2026-04-27T18:51:39-07:00Cấy ghép tế bào gốc đồng loại cải thiện sự sống sót ở bệnh nhân AML t(6;9) nguy cơ cao, đặc biệt là ở bệnh nhân trẻ tuổi và những người đạt được CR1 https://news.medxy.ai/allogeneic-stem-cell-transplant-survival/Medxy AIen2026-04-27T18:47:24-07:00Allogeneic Stem Cell Transplantation Improves Survival in High-Risk t(6;9) AML, Especially in Younger Patients and Those Achieving CR1 https://news.medxy.ai/zh/baseline-circulating-dna-biomarker/Medxy AIzh2026-04-27T16:58:34-07:00基线循环肿瘤DNA作为未治疗滤泡性淋巴瘤的预后生物标志物：来自GALLIUM试验的见解 https://news.medxy.ai/ja/untreated-ovarian-lymphoma-dna-biomarker/Medxy AIja2026-04-27T16:57:23-07:00未治療の卵巣リンパ腫における基線循環腫瘍DNAを予後バイオマーカーとしての役割：GALLIUM試験からの洞察 https://news.medxy.ai/vi/dna-biomarker-lymphoma/Medxy AIvi2026-04-27T16:56:25-07:00DNA khối u tuần hoàn cơ bản như một yếu tố dự đoán trong u lympho follicular chưa được điều trị: Những hiểu biết từ Thử nghiệm GALLIUM https://news.medxy.ai/baseline-ctdna-follicular-lymphoma/Medxy AIen2026-04-27T16:53:12-07:00Baseline Circulating Tumor DNA as a Prognostic Biomarker in Untreated Follicular Lymphoma: Insights from the GALLIUM Trial https://news.medxy.ai/zh/optimize-cml-management/Medxy AIzh2026-04-27T14:03:39-07:00优化CML管理：ASC4OPT研究和别构抑制范式的临床综合 https://news.medxy.ai/ja/cml-management-optimization/Medxy AIja2026-04-27T14:01:19-07:00CML管理の最適化：ASC4OPT試験とアルロステリック阻害パラダイムの臨床統合 https://news.medxy.ai/vi/optimizing-cml-management-2/Medxy AIvi2026-04-27T13:59:19-07:00Tối ưu hóa quản lý CML: Tổng hợp lâm sàng của nghiên cứu ASC4OPT và mô hình ức chế allosteric https://news.medxy.ai/optimizing-cml-management/Medxy AIen2026-04-27T13:56:10-07:00Optimizing CML Management: Clinical Synthesis of the ASC4OPT Study and the Allosteric Inhibition Paradigm https://news.medxy.ai/zh/vcars33-car-t-therapy-aml/Medxy AIzh2026-04-27T09:44:53-07:00供者来源的VCAR33 CAR T细胞疗法在移植后高风险AML中显示出前景 https://news.medxy.ai/ja/donor-vcar33-car-t-therapy-results/Medxy AIja2026-04-27T09:44:13-07:00ドナー由来のVCAR33 CAR T細胞療法が移植後の高リスクAMLで有望な結果を示す https://news.medxy.ai/vi/t-car-vcar33-therapy-aml/Medxy AIvi2026-04-27T09:43:21-07:00Liệu pháp tế bào T CAR VCAR33 có nguồn gốc từ người hiến tặng cho thấy triển vọng trong AML nguy cơ cao sau ghép tủy https://news.medxy.ai/donor-derived-vcar33-car-t-cell-therapy/Medxy AIen2026-04-27T09:40:18-07:00Donor-Derived VCAR33 CAR T-Cell Therapy Shows Promise in High-Risk AML Post-Transplant https://news.medxy.ai/zh/mild-copd-exacerbation-risk/Medxy AIzh2026-04-27T09:29:52-07:00轻度和单次中度慢性阻塞性肺疾病急性加重预测未来风险：基于社区队列研究的见解 https://news.medxy.ai/ja/mild-moderate-copd-exacerbation/Medxy AIja2026-04-27T09:29:13-07:00軽度および単発の中等度COPD悪化が将来のリスクを予測：コミュニティベースのコホート研究からの洞察 https://news.medxy.ai/vi/copd-outbreaks-prediction/Medxy AIvi2026-04-27T09:28:19-07:00Những đợt bùng phát COPD nhẹ và đơn lẻ vừa phải dự đoán nguy cơ trong tương lai: Những hiểu biết từ một nghiên cứu dựa vào cộng đồng https://news.medxy.ai/mild-copd-exacerbations-risk/Medxy AIen2026-04-27T09:25:21-07:00Mild and Single Moderate COPD Exacerbations Predict Future Risks: Insights from a Community-Based Cohort Study https://news.medxy.ai/zh/glp-1-receptor-agonists-vascular-protection/Medxy AIzh2026-04-27T09:24:25-07:00胰高血糖素样肽-1受体激动剂与血管保护：减轻高危2型糖尿病患者的系统性和眼部风险 https://news.medxy.ai/ja/glucagon-receptor-agonists/Medxy AIja2026-04-27T09:23:08-07:00グリカゴン様ペプチド-1受容体作動薬と血管保護：高リスク2型糖尿病患者の全身および眼疾患リスク軽減 https://news.medxy.ai/vi/glp-1-agonists-vessel-protection/Medxy AIvi2026-04-27T09:21:29-07:00Glucagon-Like Peptide-1 Receptor Agonists và Bảo Vệ Mạch Máu: Giảm Nguy Cơ Toàn Thân và Mắt ở Bệnh Nhân Đái Tháo Đường Loại 2 Có Nguy Cơ Cao https://news.medxy.ai/glp-1-receptor-agonists-vascular-protection-2/Medxy AIen2026-04-27T09:14:56-07:00Glucagon-Like Peptide-1 Receptor Agonists and Vascular Protection: Mitigating Systemic and Ocular Risks in High-Risk Type 2 Diabetes https://news.medxy.ai/zh/brolicizumab-vs-laser-therapy/Medxy AIzh2026-04-27T09:04:52-07:00布罗鲁西单抗在增殖性糖尿病视网膜病变中优于激光疗法：来自CONDOR试验的见解 https://news.medxy.ai/ja/brolucizumab-vs-laser-therapy-3/Medxy AIja2026-04-27T09:04:12-07:00Brolucizumab、レーザー療法を凌駕：CONDOR試験からの知見 https://news.medxy.ai/vi/brolucizumab-vs-laser-therapy-2/Medxy AIvi2026-04-27T09:03:33-07:00Brolucizumab hiệu quả hơn liệu pháp bằng laser trong bệnh võng mạc tiểu đường tăng sinh: Những nhận xét từ thử nghiệm CONDOR https://news.medxy.ai/brolucizumab-vs-laser-therapy/Medxy AIen2026-04-27T09:01:09-07:00Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial https://news.medxy.ai/zh/dsdo-lenses-myopia-management/Medxy AIzh2026-04-27T08:59:40-07:00DSDO 镜片在儿童近视管理中表现出更优的轴向长度控制：一项多中心真实世界研究 https://news.medxy.ai/ja/dsdo-lens-myopia-management/Medxy AIja2026-04-27T08:58:54-07:00DSDOレンズは小児近視管理における軸長制御に優れた効果を示す：実世界の多施設研究 https://news.medxy.ai/vi/dsdo-control-display-study/Medxy AIvi2026-04-27T08:57:47-07:00Kính DSDO Hiển Thị Kiểm Soát Chiều Dài Trục Siêu Việt trong Quản Lý Cận Thị Nhi Đồng: Một Nghiên Cứu Đa Trung Tâm Thực Tế https://news.medxy.ai/dsdo-lenses-pediatric-myopia/Medxy AIen2026-04-27T08:55:12-07:00DSDO Lenses Show Superior Axial Length Control in Pediatric Myopia Management: A Real-World Multicenter Study https://news.medxy.ai/ja/immunotherapy-head-and-neck-cancer/Medxy AIja2026-04-27T08:15:41-07:00頭頸部がんにおける免疫療法の処方パターンと免疫関連有害事象 https://news.medxy.ai/vi/prescription-model-immunotoxicity/Medxy AIvi2026-04-27T08:14:36-07:00Mô hình kê đơn và các tác dụng phụ liên quan đến hệ miễn dịch trong điều trị ung thư đầu cổ https://news.medxy.ai/immunotherapy-head-neck-cancer/Medxy AIen2026-04-27T08:11:10-07:00Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer https://news.medxy.ai/zh/radiation-otitis-recurrence-risk/Medxy AIzh2026-04-27T08:09:26-07:00放射诱发的分泌性中耳炎：细菌定植增加早期复发风险但缺乏长期预后价值 https://news.medxy.ai/ja/radiation-induced-ome-2/Medxy AIja2026-04-27T08:08:30-07:00放射線誘発性OME：細菌の定着が早期再発リスクを高めるが、長期予後には価値がない https://news.medxy.ai/vi/middle-ear-infection-radiation/Medxy AIvi2026-04-27T08:07:40-07:00Viêm tai giữa do xạ trị: Sự định cư của vi khuẩn làm tăng nguy cơ tái phát sớm nhưng không có giá trị tiên lượng dài hạn https://news.medxy.ai/radiation-induced-ome/Medxy AIen2026-04-27T08:04:40-07:00Radiation-Induced OME: Bacterial Colonization Elevates Early Recurrence Risk Yet Lacks Long-Term Prognostic Value https://news.medxy.ai/zh/68ga-pet-ct-aldo-surgery-outcome/Medxy AIzh2026-04-27T00:12:45-07:0068Ga-潘替克萨福 PET/CT 预测原发性醛固酮增多症手术后的预后 https://news.medxy.ai/ja/68ga-pentixafor-pet-ct-aldo-surgery-outcomes/Medxy AIja2026-04-27T00:11:27-07:0068Ga-Pentixafor PET/CT が主アルドステロン症手術の術後成績を予測 https://news.medxy.ai/vi/68ga-pentixafor-pet-ct-almost-aldosteron/Medxy AIvi2026-04-27T00:10:32-07:0068Ga-Pentixafor PET/CT Dự Đoán Kết Quả Sau Phẫu Thuật trong Bệnh Aldosteron Chủ Động https://news.medxy.ai/68ga-pentixafor-pet-ct-outcomes/Medxy AIen2026-04-27T00:07:18-07:0068Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery https://news.medxy.ai/zh/early-enteral-nutrition-complications-2/Medxy AIzh2026-04-26T23:56:54-07:00早期肠内营养减少高危胰十二指肠切除术患者的术后并发症 https://news.medxy.ai/early-enteral-nutrition-pancreatoduodenectomy/Medxy AIen2026-04-26T23:51:27-07:00Early Enteral Nutrition Reduces Postoperative Complications in High-Risk Pancreatoduodenectomy Patients https://news.medxy.ai/zh/mucosal-impedance-gerd-tool-2/Medxy AIzh2026-04-26T23:44:08-07:00黏膜阻抗：一种用于优化GERD表型和手术决策的新诊断工具 https://news.medxy.ai/ja/mucosal-impedance-gerd-tool/Medxy AIja2026-04-26T23:43:31-07:00粘膜インピーダンス：GERDの診断と手術決定の向上に向けた新規ツール https://news.medxy.ai/vi/mucosal-resistance-gerd/Medxy AIvi2026-04-26T23:42:12-07:00Độ cản trở niêm mạc: Công cụ chẩn đoán mới để cải thiện phân loại GERD và quyết định phẫu thuật https://news.medxy.ai/mucosal-impedance-gerd-diagnosis/Medxy AIen2026-04-26T23:38:48-07:00Mucosal Impedance: A Novel Diagnostic Tool for Refining GERD Phenotyping and Surgical Decision-Making https://news.medxy.ai/zh/community-centered-education-improves-minority-women-awareness/Medxy AIzh2026-04-26T23:15:41-07:00以社区为中心的教育提高了少数族裔妇女对临床试验的认知和自我效能 https://news.medxy.ai/ja/community-education-minority-women/Medxy AIja2026-04-26T23:14:43-07:00コミュニティ中心の教育がマイノリティ女性の臨床試験に関する知識と自己効力感を向上させる https://news.medxy.ai/vi/community-focused-education/Medxy AIvi2026-04-26T23:13:52-07:00Giáo dục tập trung vào cộng đồng cải thiện kiến thức và lòng tự tin tham gia thử nghiệm lâm sàng cho phụ nữ thiểu số https://news.medxy.ai/community-education-clinical-trials/Medxy AIen2026-04-26T23:11:49-07:00Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women https://news.medxy.ai/zh/optimizing-delivery-timing-2/Medxy AIzh2026-04-26T18:34:28-07:00优化肥胖妊娠的分娩时机：孕前糖尿病在死胎风险中的关键作用 https://news.medxy.ai/ja/optimal-birth-timing-obesity/Medxy AIja2026-04-26T18:33:50-07:00肥満妊娠における出産タイミングの最適化：妊娠前の糖尿病が死産リスクに及ぼす重要な役割 https://news.medxy.ai/vi/optimizing-birth-time-obesity/Medxy AIvi2026-04-26T18:33:03-07:00Tối ưu hóa thời gian sinh nở cho thai kỳ béo phì: Vai trò quan trọng của tiểu đường tiền thai kỳ trong nguy cơ thai chết lưu https://news.medxy.ai/optimizing-delivery-timing/Medxy AIen2026-04-26T18:29:44-07:00Optimizing Delivery Timing for Obese Pregnancies: The Critical Role of Pre-Pregnancy Diabetes in Stillbirth Risk https://news.medxy.ai/acog-2026-cervical-cancer-guidelines/Medxy AIen2026-04-26T09:00:07-07:00ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications